127 related articles for article (PubMed ID: 30835157)
1. Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice.
Chen L; Cui S; Yu H; Li G; Liu N; Wu Q; Zhang HT; O'Donnell JM; Wang G; Xu Y
J Psychopharmacol; 2019 May; 33(5):568-576. PubMed ID: 30835157
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior.
Huang X; Xiaokaiti Y; Yang J; Pan J; Li Z; Luria V; Li Y; Song G; Zhu X; Zhang HT; O'Donnell JM; Xu Y
Neuropharmacology; 2018 Dec; 143():176-185. PubMed ID: 30268520
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.
Chen L; Liu K; Wang Y; Liu N; Yao M; Hu J; Wang G; Sun Y; Pan J
Eur J Pharmacol; 2021 Jan; 891():173768. PubMed ID: 33271150
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior.
Yan Y; Zhao Y; Lu Y; Acharya AP; Wang W; Zhan CG; Ye J; Du F; Zhu X; Xu Y
Int J Neuropsychopharmacol; 2023 Jun; 26(6):415-425. PubMed ID: 37208298
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress-Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling.
Pan X; Chen L; Shan C; Cai L; Wang Y; Chen Y; Gu M; Liu K; Li P; Pan J
Int J Neuropsychopharmacol; 2022 Nov; 25(11):936-945. PubMed ID: 36124735
[TBL] [Abstract][Full Text] [Related]
6. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.
Masood A; Nadeem A; Mustafa SJ; O'Donnell JM
J Pharmacol Exp Ther; 2008 Aug; 326(2):369-79. PubMed ID: 18456873
[TBL] [Abstract][Full Text] [Related]
7. The antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition.
Zhu X; Li W; Li Y; Xu W; Yuan Y; Zheng V; Zhang H; O'Donnell JM; Xu Y; Yin X
Neuropharmacology; 2019 Jul; 153():20-31. PubMed ID: 31026437
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.
Xu Y; Pan J; Chen L; Zhang C; Sun J; Li J; Nguyen L; Nair N; Zhang H; O'Donnell JM
Int J Neuropsychopharmacol; 2013 May; 16(4):835-47. PubMed ID: 22850435
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanisms.
Ding L; Zhang C; Masood A; Li J; Sun J; Nadeem A; Zhang HT; O' Donnell JM; Xu Y
Behav Brain Res; 2014 Jul; 268():150-158. PubMed ID: 24694839
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior.
Zhu MJ; Shi J; Chen Y; Huang G; Zhu XW; Zhang S; Huang XF; Song GQ; Zhang HT; Ke HM; O'Donnell JM; Wang LQ; Xu Y
Psychopharmacology (Berl); 2020 Nov; 237(11):3215-3224. PubMed ID: 32926224
[TBL] [Abstract][Full Text] [Related]
11. Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal.
Wang L; Shen M; Jiang C; Ma L; Wang F
Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27385383
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide signaling via cGMP-stimulated phosphodiesterase in striatal neurons.
Lin DT; Fretier P; Jiang C; Vincent SR
Synapse; 2010 Jun; 64(6):460-6. PubMed ID: 20175220
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of the astrocytic glucocorticoid receptor in the central nucleus of the amygdala diminishes conditioned fear expression and anxiety.
Wiktorowska L; Bilecki W; Tertil M; Kudla L; Szumiec L; Mackowiak M; Przewlocki R
Behav Brain Res; 2021 Mar; 402():113095. PubMed ID: 33359366
[TBL] [Abstract][Full Text] [Related]
14. Amygdaloid involvement in the defensive behavior of mice exposed to the open elevated plus-maze.
Sorregotti T; Cipriano AC; Cruz FC; Mascarenhas DC; Rodgers RJ; Nunes-de-Souza RL
Behav Brain Res; 2018 Feb; 338():159-165. PubMed ID: 29080676
[TBL] [Abstract][Full Text] [Related]
15. GPR26-deficient mice display increased anxiety- and depression-like behaviors accompanied by reduced phosphorylated cyclic AMP responsive element-binding protein level in central amygdala.
Zhang LL; Wang JJ; Liu Y; Lu XB; Kuang Y; Wan YH; Chen Y; Yan HM; Fei J; Wang ZG
Neuroscience; 2011 Nov; 196():203-14. PubMed ID: 21924326
[TBL] [Abstract][Full Text] [Related]
16. Activation of protein kinase A in the amygdala modulates anxiety-like behaviors in social defeat exposed mice.
Yang L; Shi LJ; Yu J; Zhang YQ
Mol Brain; 2016 Jan; 9():3. PubMed ID: 26747511
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the GLT-1 Transporter in the Central Nucleus of the Amygdala Induces both Anxiety and Depressive-Like Symptoms.
John CS; Sypek EI; Carlezon WA; Cohen BM; Öngür D; Bechtholt AJ
Neuropsychopharmacology; 2015 Jun; 40(7):1700-8. PubMed ID: 25586634
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lung phosphodiesterase 2A attenuates alveolar inflammation and protein leak in a two-hit mouse model of acute lung injury.
Rentsendorj O; Damarla M; Aggarwal NR; Choi JY; Johnston L; D'Alessio FR; Crow MT; Pearse DB
Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L161-70. PubMed ID: 21571906
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterases PDE2A and PDE10A both change mRNA expression in the human brain with age, but only PDE2A changes in a region-specific manner with psychiatric disease.
Farmer R; Burbano SD; Patel NS; Sarmiento A; Smith AJ; Kelly MP
Cell Signal; 2020 Jun; 70():109592. PubMed ID: 32119913
[TBL] [Abstract][Full Text] [Related]
20. Critical role of phosphodiesterase 2A in mouse congenital heart defects.
Assenza MR; Barbagallo F; Barrios F; Cornacchione M; Campolo F; Vivarelli E; Gianfrilli D; Auletta L; Soricelli A; Isidori AM; Lenzi A; Pellegrini M; Naro F
Cardiovasc Res; 2018 May; 114(6):830-845. PubMed ID: 29409032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
